Vaidya Sane Ayurved Laboratories Limited — Others, 13-02-2025: Statement of deviation(s) or variation(s) under Reg. 32

Vaidya Sane Ayurved Laboratories Limited confirms there was no deviation in the utilization of proceeds from its recent preferential issues of convertible share warrants totaling ₹2.76 crore and ₹10.66 crore. The Audit Committee reviewed this statement, ensuring funds were allocated for intended purposes such as working capital and general corporate needs. This update signals effective governance and transparency, likely enhancing investor confidence. The absence of deviations might indicate a stable operational approach, presenting a positive outlook for shareholder interests amidst ongoing growth plans.